Clinical Trials for Pieris Pharmaceuticals

Explore 1 clinical trials worldwide

Showing 1-1 of 1 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Pieris Pharmaceuticals

Clinical Trials (1)

NCT05190445
Cinrebafusp Alfa in Combination With Ramucirumab and Paclitaxel in HER2-High Gastric or GEJ Adenocarcinoma and in Combination With Tucatinib in HER2-Low Gastric or GEJ Andenocarinoma
PHASE2Active, not recruiting
80 participants
Started: Nov 1, 2021 · Completed: Feb 1, 2023
1 condition1 sponsor5 locations